Clinical Evidence: What Weight Loss Results Show
Is Wegovy or Mounjaro Better for Weight Loss: Understanding the Clinical Evidence
When evaluating whether Wegovy or Mounjaro is better for weight loss, the clinical trial evidence provides crucial insights for UK patients. Wegovy's efficacy has been demonstrated through the comprehensive STEP clinical trial programme, with STEP 1 showing patients achieved approximately 15% average weight loss at 68 weeks when taking Wegovy alongside diet and exercise interventions. The SELECT cardiovascular outcomes trial further demonstrated a 20% reduction in major cardiovascular events, highlighting Wegovy's broader health benefits beyond weight management.
Mounjaro's clinical profile stems from the SURMOUNT trial programme, though direct head-to-head comparisons between Wegovy and Mounjaro remain limited due to different trial designs, patient populations, and endpoints. Both medications represent significant advances in weight management, with your prescriber at EverydayMeds best positioned to evaluate which treatment suits your individual circumstances. The question of whether Wegovy or Mounjaro is better for weight loss ultimately depends on your medical history, treatment goals, and how you respond to each medication's unique mechanism of action.
Wegovy vs Mounjaro Pricing: Weight Loss Investment in the UK
Understanding the cost implications when deciding if Wegovy or Mounjaro is better for weight loss helps UK patients make informed decisions. Wegovy starts at £79.99 for the 0.25mg starter dose at EverydayMeds, with our FIRST40 discount code applied at checkout for new customers. The complete dose escalation includes 0.5mg at £94.99, 1mg at £99.99, 1.7mg at £139.99, and the 2.4mg maintenance dose at £209.99. Our Getting Started bundles provide convenient multi-dose packages, such as the Intro Duo (0.25mg and 0.5mg) for £169.99, designed to support your initial treatment journey.
When comparing whether Wegovy or Mounjaro is better for weight loss from a value perspective, both medications require ongoing investment as prescription-only medicines. EverydayMeds offers flexible purchasing options including our Take-It-Slow bundles for patients who prefer extended dose phases, and our Ultimate Stability Trio providing three months of 2.4mg maintenance supply for £649.99. Returning customers benefit from our DOSE25 discount code, making long-term weight management more accessible. Both Wegovy and Mounjaro are available through our regulated UK pharmacy, with your prescriber helping determine the most suitable and cost-effective treatment approach for your weight loss goals.
STEP Trial Evidence: Does Wegovy Work for UK Weight Loss?
The landmark STEP trials provide compelling evidence when evaluating whether Wegovy or Mounjaro is better for weight loss outcomes. STEP 1, published by Wilding et al. in NEJM 2021, demonstrated that patients taking Wegovy alongside diet and exercise achieved approximately 15% average weight loss at 68 weeks compared to 2.4% with placebo. STEP 3 combined Wegovy with intensive behavioural therapy, resulting in approximately 16% average weight loss, while STEP 5 showed sustained weight loss of 15.2% at two years.
These clinical trial results help inform the decision of whether Wegovy or Mounjaro is better for weight loss, though individual responses may vary significantly. The SELECT cardiovascular outcomes trial added important safety and efficacy data, showing a 20% reduction in major cardiovascular events among patients taking Wegovy. When considering if Wegovy or Mounjaro is better for weight loss, these peer-reviewed clinical trials provide evidence-based foundation for treatment decisions, though your individual results will depend on adherence to prescribed lifestyle modifications and your body's response to treatment.
How Wegovy Works: GLP-1 Mechanism for Weight Management
Understanding Wegovy's mechanism helps clarify whether Wegovy or Mounjaro is better for weight loss in your specific situation. Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics a natural hormone produced in your intestines after eating. This prescription-only medicine works by reducing appetite, promoting feelings of fullness after smaller meals, and may help reduce food cravings by acting on brain appetite centres. The once-weekly injection using the FlexTouch pen provides consistent medication levels, supporting sustained appetite control throughout the week. Unlike Mounjaro, which targets both GIP and GLP-1 receptors, Wegovy focuses exclusively on GLP-1 pathways, offering a well-established mechanism with extensive clinical trial data supporting its weight management effects.
EverydayMeds Ordering Process: Getting Wegovy in the UK
When deciding whether Wegovy or Mounjaro is better for weight loss, EverydayMeds streamlines access to both treatments through our regulated UK pharmacy process. The journey begins with a comprehensive 3-minute online clinical assessment, covering your medical history, current medications, weight management goals, and lifestyle factors. Our qualified prescribers review your assessment within standard 3 working days, or 24 hours with express review, ensuring safe and appropriate treatment selection. Once approved, Wegovy is dispatched via next-day delivery using temperature-controlled cold-chain logistics, maintaining the medication's integrity from our GPhC-registered pharmacy (#9012878) to your door. This regulated process ensures that whether Wegovy or Mounjaro is better for weight loss in your case, you receive appropriate medical oversight and genuine medication through legitimate healthcare channels.
Storage and Practical Considerations: Wegovy vs Mounjaro Comparison
Practical storage differences may influence whether Wegovy or Mounjaro is better for weight loss in your lifestyle. Wegovy requires refrigeration at 2-8°C before first use but offers superior room temperature stability, remaining effective for up to 6 weeks below 30°C once removed from the fridge. This compares favourably to Mounjaro's 21-day room temperature limit, making Wegovy more suitable for travel or situations where refrigeration access is limited. The FlexTouch pen design provides user-friendly injection experience, with clear dose indicators and automatic needle insertion. Wegovy follows a mandatory dose escalation schedule starting at 0.25mg for weeks 1-4, progressing through 0.5mg, 1mg, and 1.7mg phases before reaching the 2.4mg maintenance dose, allowing your body to gradually adjust to treatment effects while minimising potential side effects.
UK Weight Loss Results: Real-World Wegovy vs Mounjaro Outcomes
When evaluating whether Wegovy or Mounjaro is better for weight loss based on UK patient experiences, both medications have shown significant real-world effectiveness beyond clinical trial settings. Wegovy's established track record in the UK market, combined with NICE guidance TA875 recommending its use with specialist weight management support, provides confidence in its clinical utility. Patient testimonials and prescriber feedback suggest that individual responses vary considerably, with some patients responding better to Wegovy's single-target GLP-1 approach while others may benefit from Mounjaro's dual-hormone mechanism.
The question of whether Wegovy or Mounjaro is better for weight loss often depends on factors beyond pure efficacy, including side effect tolerance, injection frequency preferences, and storage requirements. EverydayMeds' clinical team reports that successful weight loss outcomes with either medication require consistent adherence to prescribed lifestyle modifications, including reduced-calorie diet and increased physical activity. Both medications are available through our regulated pharmacy, with prescribers able to switch between treatments if initial results don't meet expectations, ensuring UK patients receive optimal weight management support regardless of which option proves most suitable.
Making Your Choice: Wegovy and Mounjaro Available at EverydayMeds
Rather than definitively answering whether Wegovy or Mounjaro is better for weight loss, EverydayMeds recognises that optimal treatment depends on individual patient factors and medical circumstances. Both medications are available through our comprehensive service, starting with Wegovy at £79.99 using discount code FIRST40 for new customers, or DOSE25 for returning patients. Our qualified prescribers conduct thorough assessments to determine which treatment aligns best with your health profile, weight management goals, and lifestyle requirements. The regulated supply through our GPhC-registered pharmacy (#9012878) ensures you receive genuine medication with appropriate medical oversight, whether you begin with Wegovy's established GLP-1 approach or opt for Mounjaro's dual-hormone mechanism. Both Wegovy and Mounjaro represent significant advances in weight management, and EverydayMeds provides the clinical support and pharmaceutical expertise to help you achieve sustainable results with either treatment option.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
